PCM
ACGN

Prelude Capital Management’s Aceragen Inc ACGN Stock Holding History

Prelude Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,189
Closed -$26K – 2071
2021
Q1 		$26K Buy
+1,189
New +$89.1K ﹤0.01% 1475

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Prelude Capital Management's ACGN Position: Q2 2017 in Review

Prelude Capital Management sold out of Aceragen Inc (ACGN) in Q2 2017, closing a stake of 71 shares — an estimated $24K sold.

Prelude Capital Management first reported a position in ACGN in Q1 2017 and held it in 1 quarter. The position peaked at $24K in Q1 2017. 78 funds tracked by Wall St. Rank hold ACGN as of Q2 2017.

  • Prelude Capital Management reported no remaining Aceragen Inc position as of Q2 2017 after selling out during the quarter.
  • Prelude Capital Management sold 71 Aceragen Inc shares in Q2 2017, an estimated $24K.
  • Prelude Capital Management first reported a position in Aceragen Inc in Q1 2017 and held it in 1 quarter.
  • Prelude Capital Management's Aceragen Inc position peaked at $24K in Q1 2017.
  • 78 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2017.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.